On December 26, 2024, Park Ha Biological Technology Co., Ltd. entered an underwriting agreement for an IPO to sell 1.2 million shares at $4.00 each. On January 22, 2025, they partially exercised the option to sell an additional 174,403 shares, raising $697,612, with the closing on January 24, 2025.